Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Inc. (NYSE: HUM) and Mays Business School at Texas A&M University announced the winners of the 2022 Humana-Mays Healthcare Analytics Case Competition. This year's competition attracted over 550 master’s level students from 48 universities, competing for a total of $80,000 in prizes. UCLA's team won first place with a prize of $50,000. The focus was on health-related social needs, particularly housing insecurity. Humana emphasized its commitment to addressing social determinants of health through advanced analytics.
Humana Inc. (NYSE: HUM) has successfully completed a $1.25 billion public offering of senior notes. This includes $500 million in 5.750% senior notes due in 2028 and $750 million in 5.875% senior notes due in 2033. The expected net proceeds are approximately $1.232 billion, primarily earmarked for repaying existing senior notes maturing in December 2022 and general corporate purposes. The offerings were managed by BofA Securities, Goldman Sachs, J.P. Morgan, and PNC Capital Markets. The company is subject to various risks, including those linked to healthcare costs and COVID-19 impacts.
Humana Inc. has opened its second CarePlus Community Center in
CenterWell Senior Primary Care plans to expand in 2023, announcing the opening of 30 to 35 new centers in markets including Virginia, Mississippi, and Indiana, as well as existing states like Louisiana, Texas, and South Carolina. This initiative is part of a joint venture with Welsh, Carson, Anderson & Stowe. CenterWell focuses on providing senior-focused primary care, operating over 220 centers across 11 states, and aims for continued growth of 30-50 centers annually through 2025. The model emphasizes enhanced doctor-patient relationships, improving health outcomes and patient satisfaction.
Humana has been recognized as the leading insurance company for Medicare Advantage plans in 2023 by U.S. News & World Report, excelling in three key categories: overall rating, member experience, and low-premium plan availability.
With 4.9 million members, or 96%, enrolled in plans rated 4 stars and above, Humana emphasizes quality care and customer service. The recognition follows a strong performance in CMS Star ratings, which evaluate plans on a 1-to-5 star scale. Humana’s commitment to enhancing health outcomes for Medicare beneficiaries has helped solidify its top position in the industry.
CenterWell Senior Primary Care is set to launch three new primary care centers in Louisville, Kentucky, enhancing access to senior-focused healthcare. These centers, part of CenterWell's expansion plan, will incorporate a team-based approach to care. With over 220 centers currently operational, they plan to open 30-50 more annually by 2025. A notable community contribution includes $20,000 donated to local non-profits. The first center began operating on October 24, with upcoming openings on November 21 and January 17.
AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana Inc. (HUM) for its $500 million of 5.75% senior unsecured notes due March 1, 2028, and $750 million of 5.875% senior unsecured notes due March 1, 2033. The outlook for the ratings is stable. Proceeds are expected to refinance $1 billion in debt due in December and for general corporate purposes. Humana maintains a financial leverage of 41%, which is in line with industry standards, while targeting a debt-to-capital ratio below 40%.
Humana Inc. (NYSE: HUM) has priced a public offering of $1.25 billion in senior notes, including $500 million of 5.75% notes due 2028 and $750 million of 5.875% notes due 2033. The offering is set to close on November 22, 2022. The expected net proceeds of approximately $1.232 billion will be used to repay existing senior notes due in December 2022 and for general corporate purposes. The offerings are made under an effective shelf registration statement with the SEC.
Humana Inc. (NYSE: HUM) reported 3Q22 GAAP EPS of $9.39 and adjusted EPS of $6.88, with YTD 2022 GAAP EPS at $22.16 and adjusted EPS at $23.58. The company raised FY 2022 guidance to approximately $23.27 GAAP EPS and affirmed an adjusted EPS target of $25.00, showing 21% growth from FY 2021. Humana leads in Medicare Advantage Star ratings, with 96% of members in contracts rated 4 stars or higher. It expects growth of 325,000 to 400,000 Medicare Advantage members in 2023, aligning with industry trends.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
